Emerging issues related to COVID-19 vaccination in patients with cancer.
Oncol Ther
; 9(2): 255-265, 2021 Dec.
Article
in English
| MEDLINE | ID: covidwho-1275018
ABSTRACT
Coronavirus disease 2019 (COVID-19) has resulted in millions of deaths globally. The pandemic has had a severe impact on oncology care and research. Patients with underlying cancer are more vulnerable to contracting COVID-19, and also have a more severe clinical course following the infection. The rollout of COVID-19 vaccines in many parts of the world has raised hopes of controlling the pandemic. In this editorial, the authors outline key characteristics of the currently approved COVID-19 vaccines, provide a brief overview of key emerging issues such as vaccine-induced immune thrombotic thrombocytopenia and SARS-CoV-2 variants of concern, and review the available data related to the efficacy and side effects of vaccinating patients with cancer.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Type of study:
Prognostic study
Topics:
Vaccines
/
Variants
Language:
English
Journal:
Oncol Ther
Year:
2021
Document Type:
Article
Affiliation country:
S40487-021-00157-1
Similar
MEDLINE
...
LILACS
LIS